Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richa Singhal

Showing results (71-80 of 72) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 72 results.
Malaria Journal|May 7, 2026
Protocol for a multicentric open-label randomized controlled trial comparing low-dose (0.25 mg/kg) and standard-dose (0.75 mg/kg) primaquine for gametocytocidal efficacy and safety in Plasmodium falciparum malariaPayal Gulati, Richa Singhal, Apoorv Gupta, et al.
BMJ Open|July 4, 2024
Community perspective and healthcare assessment in malaria endemic states of India: a cross-sectional study protocolShrinivasa B M, Vani H C, Richa Singhal, et al.
Pageof 8

Showing results (71-80 of 72) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 72 results.
Malaria Journal|May 7, 2026
Protocol for a multicentric open-label randomized controlled trial comparing low-dose (0.25 mg/kg) and standard-dose (0.75 mg/kg) primaquine for gametocytocidal efficacy and safety in Plasmodium falciparum malariaPayal Gulati, Richa Singhal, Apoorv Gupta, et al.
BMJ Open|July 4, 2024
Community perspective and healthcare assessment in malaria endemic states of India: a cross-sectional study protocolShrinivasa B M, Vani H C, Richa Singhal, et al.
Pageof 8